A multicenter Brazilian study finds intravenous esketamine produced faster antidepressant response in treatment-resistant ...
Panelists discuss how incorporating subcutaneous (SubQ) formulations into clinical formularies requires careful evaluation of clinical equivalence, workflow fit, and reimbursement logistics, with ...
Panelists discuss how transitioning patients from intravenous (IV) to subcutaneous (SubQ) therapies demands a coordinated, multidisciplinary approach—integrating clinical judgment, electronic medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results